Heparin is an injectable anti-coagulant indicated in the treatment of venous thromboembolic diseases. In the case of major kidney failure, unfractionated heparins (UFHs) can be administered while low molecular weight heparins (LMWHs) are contraindicated at a curative dose. Platelet count must be monitored in patients treated with UFHs and when an LMWH is prescribed in a surgical context.
Keywords: anticoagulant; cancer; fondaparinux; grossesse; heparin; héparine; induced thrombocytopaenia; pregnancy; thrombopénie induite; thrombose; thrombosis.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.